Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 9/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.63 |
| ▸ | CYP19A1 | P11511 | 8/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 7/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 7/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 6/20 | 0.58 |
| ▸ | RARB | P10826 | 4/20 | 0.54 |
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | DRD2 | P14416 | 1/20 | 0.51 |
| ▸ | DRD4 | P21917 | 1/20 | 0.51 |
| ▸ | DRD3 | P35462 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2357155 | 0.96 | CYP2D6 (0.59) | CYP2D6CYP3A4CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL4867079 | 0.94 | RARB (0.61) | CYP2D6CYP3A4CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL2356972 | 0.94 | RARB (0.61) | CYP2D6CYP3A4CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL2356412 | 0.94 | RARB (0.61) | CYP2D6CYP3A4CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL12972983 | 0.94 | RARB (0.61) | CYP2D6CYP3A4CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL7697448 | 0.94 | RARB (0.61) | CYP2D6CYP3A4CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL1792760 | 0.94 | RARB (0.61) | CYP2D6CYP3A4CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL916469 | 0.94 | LTA4H (0.57) | CYP2D6CYP3A4CYP1A2LTA4HSMN1; SMN2 | |
| SCHEMBL9155411 | 0.92 | MAPT (0.55) | CYP2D6CYP3A4CYP19A1CYP2C9CYP2C19 | |
| SCHEMBL11578764 | 0.91 | LTA4H (0.55) | CYP2D6CYP3A4CYP1A2LTA4HSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100143980-A1 | SYNTHESIS OF NOVEL XYLOSIDES AND POTENTIAL USES THEREOF | BALAGURUNATHAN KUBERAN | 2010-06-10 | — | — | US | disclosed |
| EP-0788511-B1 | CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO (JP) | 2002-12-11 | — | — | EP | disclosed |
| EP-0872484-B1 | ORGANOSILICON COMPOUNDS, LIQUID-CRYSTAL COMPOSITION, AND LIQUID-CRYSTAL DISPLAY ELEMENT | CHISSO CORP (JP) | 2002-10-02 | — | — | EP | disclosed |
| US-6265536-B1 | MICROBIOCIDE AND FUNGICIDE WHICH IS INHIBITOR OF BETA-1,3-GLUCAN SYNTHASE; TREATMENT OF PNEUMOCYSTIS CARINII INFECTION | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-07-24 | — | — | US | disclosed |
| US-6107458-A | FUNGICIDE WHICH IS BETA-1,3-GLYCAN SYNTHASE INHIBITOR; FOR PROPHYLAXIS AND TREATMENT OF PNEUMOCYSTIS CARINII INFECTIONS LIKE PNEUMONIA | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-08-22 | — | — | US | disclosed |
| US-5993690-A | Organosilicon compound, liquid crystal composition, and liquid-crystal display element | CHISSO CORPORATION (JP) | 1999-11-30 | — | — | US | disclosed |
| EP-0872484-A1 | ORGANOSILICON COMPOUNDS, LIQUID-CRYSTAL COMPOSITION, AND LIQUID-CRYSTAL DISPLAY ELEMENT | CHISSO CORPORATION (JP) | 1998-10-21 | — | — | EP | disclosed |
| EP-0788511-A1 | CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-08-13 | — | — | EP | disclosed |
| WO-1996011210-A1 | CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-04-18 | — | — | WO | disclosed |
| EP-0343606-B1 | An engineering plastic composition and an article made of the same | SEIKISUI CHEMICAL CO LTD (JP) | 1995-01-18 | — | — | EP | disclosed |
| US-5011879-A | With adjuvants of p-quaterphenyl or its hydroxy, alkoxy or alkyl ester derivatives; melt viscosity, heat resistance, molding materials | SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1991-04-30 | — | — | US | disclosed |
| EP-0343606-A1 | An engineering plastic composition and an article made of the same | SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1989-11-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100143980-A1 | SYNTHESIS OF NOVEL XYLOSIDES AND POTENTIAL USES THEREOF | CSGALNACT1, ST3GAL3, FUT6 | CYP2D6 497/4885CYP3A4 1078/4885CYP19A1 2613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.